Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considerin...
- Autores:
-
Carabali, Mabel
Kyungah Lima, Jacqueline
Vélez, Diana Carolina
Trujillo Correa, Andrea Isabel
Egurrola Pedraza, Jorge Armando
Sung Lee, Kang
Kaufman, Jay S.
DaSilva, Luiz Jacinto
Vélez Bernal, Iván Darío
Osorio Benítez, Jorge Emilio
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2017
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/27884
- Acceso en línea:
- http://hdl.handle.net/10495/27884
- Palabra clave:
- Dengue
Prevalence
Prevalencia
Seroconversion
Viral Load
Carga Viral
Child
Niño
Adult
Adulto
Colombia
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id |
UDEA2_fa98e7275995044748b36aa0c4b1421f |
---|---|
oai_identifier_str |
oai:bibliotecadigital.udea.edu.co:10495/27884 |
network_acronym_str |
UDEA2 |
network_name_str |
Repositorio UdeA |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
title |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
spellingShingle |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction Dengue Prevalence Prevalencia Seroconversion Viral Load Carga Viral Child Niño Adult Adulto Colombia |
title_short |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
title_full |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
title_fullStr |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
title_full_unstemmed |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
title_sort |
Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction |
dc.creator.fl_str_mv |
Carabali, Mabel Kyungah Lima, Jacqueline Vélez, Diana Carolina Trujillo Correa, Andrea Isabel Egurrola Pedraza, Jorge Armando Sung Lee, Kang Kaufman, Jay S. DaSilva, Luiz Jacinto Vélez Bernal, Iván Darío Osorio Benítez, Jorge Emilio |
dc.contributor.author.none.fl_str_mv |
Carabali, Mabel Kyungah Lima, Jacqueline Vélez, Diana Carolina Trujillo Correa, Andrea Isabel Egurrola Pedraza, Jorge Armando Sung Lee, Kang Kaufman, Jay S. DaSilva, Luiz Jacinto Vélez Bernal, Iván Darío Osorio Benítez, Jorge Emilio |
dc.subject.decs.none.fl_str_mv |
Dengue Prevalence Prevalencia Seroconversion Viral Load Carga Viral Child Niño Adult Adulto |
topic |
Dengue Prevalence Prevalencia Seroconversion Viral Load Carga Viral Child Niño Adult Adulto Colombia |
dc.subject.proposal.spa.fl_str_mv |
Colombia |
description |
ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considering its introduction. Methods: A community-based survey was conducted to estimate dengue seroprevalence and age-specific seroconversion rates in a community in Medellin, Colombia, using a dengue serological test (IgG indirect ELISA). Residents were selected at random and were first screened for dengue infection; they were then followed over 2.5 years. Results: A total of 3684 individuals aged between 1 and 65 years participated in at least one survey. The overall dengue seroprevalence was 61%, and only 3.3% of seropositive subjects self-reported a past history of dengue. Among dengue virus (DENV)-naïve subjects with more than two visits (n=1002), the overall seroconversion rate was 8.7% (95% confidence interval 7.3-10.4) per 1000 person-months, over the study period. Overall, the mean age of DENV prevalent subjects was significantly higher than the mean age of seroconverted subjects. Specifically, DENV seropositivity over 70% was observed in participants over 21 years old. Serotype-specific plaque-reduction neutralization tests (PRNT) revealed that all four dengue serotypes were circulating, with DENV4 being most prevalent. Conclusions: These laboratory-based findings could inform dengue vaccine decisions, as they provide age-specific seroprevalence and seroconversion data, evidencing permanent and ongoing dengue transmission in the study area. This study provides evidence for the existing rates of secondary and heterotypic responses, presenting a challenge that must be addressed adequately by the new vaccine candidates |
publishDate |
2017 |
dc.date.issued.none.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2022-04-26T20:26:25Z |
dc.date.available.none.fl_str_mv |
2022-04-26T20:26:25Z |
dc.type.spa.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.hasversion.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.redcol.spa.fl_str_mv |
https://purl.org/redcol/resource_type/ART |
dc.type.local.spa.fl_str_mv |
Artículo de investigación |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.issn.none.fl_str_mv |
1201-9712 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/10495/27884 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.ijid.2017.02.016 |
identifier_str_mv |
1201-9712 10.1016/j.ijid.2017.02.016 |
url |
http://hdl.handle.net/10495/27884 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofjournalabbrev.spa.fl_str_mv |
Int. J. Infect. Dis. |
dc.rights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ |
dc.rights.accessrights.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.creativecommons.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/2.5/co/ http://purl.org/coar/access_right/c_abf2 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.format.extent.spa.fl_str_mv |
10 |
dc.format.mimetype.spa.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Elsevier ; International Society for Infectious Diseases |
dc.publisher.group.spa.fl_str_mv |
Programa de Estudio y Control de Enfermedades Tropicales (PECET) |
dc.publisher.place.spa.fl_str_mv |
Hamilton, Canadá |
institution |
Universidad de Antioquia |
bitstream.url.fl_str_mv |
http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/2/license_rdf http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/3/license.txt http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/1/VelezIvan_2017_DengueSerologicalSurvey.pdf |
bitstream.checksum.fl_str_mv |
b88b088d9957e670ce3b3fbe2eedbc13 8a4605be74aa9ea9d79846c1fba20a33 d51f55363914d4871589420b989066d0 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad de Antioquia |
repository.mail.fl_str_mv |
andres.perez@udea.edu.co |
_version_ |
1812173074974375936 |
spelling |
Carabali, MabelKyungah Lima, JacquelineVélez, Diana CarolinaTrujillo Correa, Andrea IsabelEgurrola Pedraza, Jorge ArmandoSung Lee, KangKaufman, Jay S.DaSilva, Luiz JacintoVélez Bernal, Iván DaríoOsorio Benítez, Jorge Emilio2022-04-26T20:26:25Z2022-04-26T20:26:25Z20171201-9712http://hdl.handle.net/10495/2788410.1016/j.ijid.2017.02.016ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considering its introduction. Methods: A community-based survey was conducted to estimate dengue seroprevalence and age-specific seroconversion rates in a community in Medellin, Colombia, using a dengue serological test (IgG indirect ELISA). Residents were selected at random and were first screened for dengue infection; they were then followed over 2.5 years. Results: A total of 3684 individuals aged between 1 and 65 years participated in at least one survey. The overall dengue seroprevalence was 61%, and only 3.3% of seropositive subjects self-reported a past history of dengue. Among dengue virus (DENV)-naïve subjects with more than two visits (n=1002), the overall seroconversion rate was 8.7% (95% confidence interval 7.3-10.4) per 1000 person-months, over the study period. Overall, the mean age of DENV prevalent subjects was significantly higher than the mean age of seroconverted subjects. Specifically, DENV seropositivity over 70% was observed in participants over 21 years old. Serotype-specific plaque-reduction neutralization tests (PRNT) revealed that all four dengue serotypes were circulating, with DENV4 being most prevalent. Conclusions: These laboratory-based findings could inform dengue vaccine decisions, as they provide age-specific seroprevalence and seroconversion data, evidencing permanent and ongoing dengue transmission in the study area. This study provides evidence for the existing rates of secondary and heterotypic responses, presenting a challenge that must be addressed adequately by the new vaccine candidates001509910application/pdfengElsevier ; International Society for Infectious DiseasesPrograma de Estudio y Control de Enfermedades Tropicales (PECET)Hamilton, Canadáinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introductionDenguePrevalencePrevalenciaSeroconversionViral LoadCarga ViralChildNiñoAdultAdultoColombiaInt. J. Infect. Dis.International Journal of Infectious Diseases273658CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53ORIGINALVelezIvan_2017_DengueSerologicalSurvey.pdfVelezIvan_2017_DengueSerologicalSurvey.pdfArtículo de investigaciónapplication/pdf1993651http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/1/VelezIvan_2017_DengueSerologicalSurvey.pdfd51f55363914d4871589420b989066d0MD5110495/27884oai:bibliotecadigital.udea.edu.co:10495/278842022-05-09 11:46:40.185Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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 |